Published in Pharma Investments, Ventures and Law Weekly, December 10th, 2006
This trend article about University of Toronto, Canada, is an immediate alert from NewsRx to identify developing directions of research.
Study 1: Researchers detail in "TAT-mediated intracellular delivery of purine nucleoside phosphorylase corrects its deficiency in mice," new data in . According to recent research from Toronto, Canada, "Defects in purine nucleoside phosphorylase (PNP) enzyme activity result in abnormal nucleoside homeostasis, severe T cell immunodeficiency, neurological dysfunction, and early death. Protein transduction domain (PTD) can transfer molecules into...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.